Notably, MAPK15 has been found to enhance cisplatin toxicity in various cancer cells and may be a potential therapeutic target [75,76], whereas the interactions between other model genes and cisplatin sensitivity are yet to be fully clarified. Here, MAPK15 is linked to cancer.